The purpose of this study was to estimate the extent of potential antidepressant overprescribing in a geographically defined U.S. population, and to determine the indications and factors that account for it. We conducted a cohort study of new antidepressant prescriptions for elderly residents of Olmsted County, Minnesota, 2005-2012, using the Rochester Epidemiology Project medical records-linkage system. Indications for antidepressants were abstracted from health records for all cohort members. Potential antidepressant overprescribing was defined based on regulatory approval, the level of evidence identified from a standardized drug information database, and multidisciplinary expert review. Predictors of potential antidepressant overprescribing were investigated using logistic regression models, stratified by general antidepressant indication (general medical indication, specific psychiatric diagnosis, and non-specific psychiatric symptoms). Potential antidepressant overprescribing occurred in 24% of 3199 incident antidepressant prescriptions during the study period, and involved primarily newer antidepressants that were prescribed for non-specific psychiatric symptoms and subthreshold diagnoses.
| INTRODUCTION
In the last 30 years, there have been large increases in the use of antidepressants, which are among the most commonly prescribed medications in the U.S. 1, 2 Although increases in antidepressant prescribing have occurred across the age spectrum, 3, 4 the largest increases have occurred in elderly persons. 5, 6 The rapid growth of antidepressant use in elderly populations has raised questions about the appropriateness of this practice. 7 Evidence suggests that medication prescribing for many chronic health conditions in elderly persons is often inappropriate, 8 with associated increases in morbidity and economic burden. 9 In the case of antidepressants, available studies also suggest that potential overprescribing may be common among elderly persons, 10, 11 an important consideration given that some antidepressants, particularly those with anticholinergic side-effects, are associated with potentially serious health risks when taken by older adults. 12 Yet, questions remain about the extent of potential antidepressant overprescribing in elderly patients, and the specific indications and factors that account for it. Most of the available studies used data from surveys or electronic databases to investigate antidepressant prescribing practices among elderly persons nested within large patient cohorts. [13] [14] [15] [16] [17] [18] [19] However, the antidepressant indications were inferred using diagnosis codes or self-report, which may not have accurately accounted for the specific intended antidepressant indications. [13] [14] [15] In addition, several studies employed rudimentary definitions of antidepressant overprescribing, such as the absence of a psychiatric diagnosis, off-label antidepressant use, or the prescribing of antidepressants that appear on drug-to-avoid lists. 16, [20] [21] [22] [23] These approaches are reliable, but may overlook acceptable non-psychiatric and off-label indications for antidepressants, including those with few alternative treatments, and may inaccurately consider some medications to be always inappropriate to prescribe to elderly persons without taking into consideration implicit factors such as medical context and clinical judgment. As a result, some authors have suggested that a combination of explicit and implicit methods for defining overprescribing may be more useful than the use of either approach individually. 24 We thus conducted a cohort study of new antidepressant prescriptions given to elderly residents of Olmsted County, Minnesota 
| MATERIALS AND METHODS

| Study population
We used the medical records-linkage system of the REP to identify all persons aged ≥65 years who received an antidepressant prescription between 1/1/2005 and 12/31/2012, and had continuous residence in Olmsted County, MN during the year preceding the date of the first qualifying antidepressant prescription (n = 4754). We excluded persons who had not given permission to use their medical records for research (<3% of the overall population). The REP captures nearly the entire population of Olmsted County as compared to U.S. Census estimates. 25 Extensive details about the REP have been reported elsewhere. 25, 26 Information on the age, sex, and selfreported race was obtained electronically from computerized REP indexes. The study was approved by the Institutional Review Boards of the Mayo Clinic (MC) and the Olmsted Medical Center (OMC).
| Drug prescription records
All inpatient (at the time of discharge) and outpatient drug prescrip- Combination drugs with multiple ingredients were counted under the NDF-RT category for the main ingredient or under a combination drug category when applicable. Specific drug exposure data elements included drug name, form, dosage, frequency, quantity prescribed, date prescribed, and number of refills. The days of supply for a given prescription were calculated using the following formula: Days of supply = (quantity prescribed/number of pills to be taken per day)*
(1 + number of refills).
| Incident antidepressant prescriptions
Antidepressant drug prescriptions were electronically extracted for all persons aged ≥65 years during the study period using the aforementioned approach (Supplementary Table S1 ). The index date was defined as the date of the earliest qualifying antidepressant prescription-that is, the first prescription for an antidepressant during the study period. Incident antidepressant prescriptions were then identified based on having no evidence of antidepressant prescriptions within 180 days preceding the index date, and having no days of supply from older non-qualifying antidepressant prescriptions extending into the 180 day time window preceding the index date.
Vortioxetine was approved in the U.S. for treating major depression in 2013, and was therefore not included as a study drug.
A hierarchical list of antidepressant classes was used to identify a primary antidepressant in cases of antidepressant combination pharmacotherapy (the prescribing of two or more antidepressants on or within 15 days of the index date). However, no incident use of two or more antidepressants was observed in this time window.
| Review of health records
Electronic and paper health records of all cohort members with a qualifying antidepressant prescription according to REP prescription records were reviewed to verify that the qualifying prescriptions were incident prescriptions, and to then confirm subject age and the antidepressant drug name and dose on the index date.
Additional data for study variables were also extracted from cohort members' health records on the index date and in the preceding 365 days. This information included the setting of the visit resulting in an antidepressant prescription, specialty of the antidepressant prescriber, cohort member residence (community dwelling, nursing home/ assisted living), general medical and psychiatric comorbidity, and variables indicating medical service use (total number of outpatient visits, emergency room visits, hospitalizations, and number of health care
providers that issued any prescription during the 365 days prior to the index date). General medical comorbidity was defined as the total number of chronic non-psychiatric health conditions (non-communicable illness; and not cured once acquired or anticipated to last ≥3 months 29 ) that were under active management on the index date or in the preceding 365 days based on medical record review.
| Antidepressant indications
For each cohort member, the antidepressant indication specified in health records on the index date was abstracted. In most cases, this included a specific psychiatric or general medical diagnosis. When nonspecific psychiatric complaints or symptoms were listed as the antidepressant indication, the verbatim text from all clinical notes on the index date that referred to the signs or symptoms prompting the antidepressant prescription was abstracted for further review (discussed below).
When the text from clinical notes on the index date referenced other clinical notes written prior to the index date, the relevant verbatim text from those earlier clinical notes was also abstracted.
| Potential antidepressant overprescribing
A list of acceptable indications for specific antidepressants or antidepressant classes was constructed via a two-step process. First, information from the U.S. 
| Statistical analysis
The associations between independent variables and potential antidepressant overprescribing were investigated using univariate logistic regression, with stratification by general antidepressant indication (general medical diagnosis, specific psychiatric diagnosis, and non-specific psychiatric symptoms). The independent variables for The percent values represent the proportion of persons with the given characteristic (i.e., the rows within a characteristic sum to 100%). P-values are for statistical comparisons of the distribution of characteristics across indication types. For example, there are significant differences in the age distribution of persons across the three indication groups. Only 11.7% of persons with a general medical indication for AD prescriptions were ≥ 85 y of age, whereas the frequencies of persons ≥ 85 y of age with a specific psychiatric indication or with a non-specific psychiatric indication were higher (19.7% and 26.1%, respectively). Tables 1-3 ). Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using robust standard errors. Statistical testing for linear trends in ORs was conducted, where relevant, by equidistant coding of each stratum (e.g., 0, 1, 2, etc.). All statistical tests were two-sided at the 0.05 alpha level, and all analyses were performed using SAS statistical software (version 9.4 SAS Institute Inc., Cary, NC).
| RESULTS
As shown in Table 1 , the study cohort was predominantly White and included more women than men. A total of 3199 incident antidepressant prescriptions occurred during the study period. The most commonly prescribed antidepressants were selective serotonin reuptake inhibitors (SSRIs, 44% of antidepressant prescriptions during the study period), trazodone/nefazodone (20%, nearly all for trazodone), tricyclic antidepressants (TCAs, 16%), and mirtazapine (12%). The majority (57%) of antidepressant prescriptions were for specific psychiatric indications, whereas a roughly equal proportion of prescriptions were for non-specific psychiatric symptoms (22%) and general medical diagnoses (21%).
Potential antidepressant overprescribing occurred in nearly 24% of all incident antidepressant prescriptions. SSRIs accounted for the majority (74%) of the 758 prescriptions with potential overprescribing, followed by mirtazapine (19%). The proportion of prescriptions classified as potential overprescribing within each drug class, regardless of indication, was highest for SSRIs (40.6%), followed by mirtazapine (37.5%) and serotonin-norepinephrine reuptake inhibitor (SNRIs) (8.7%). As shown in Table 2 , the proportions of prescriptions classified as potential overprescribing within each drug class were highest for SSRIs, SNRIs, and mirtazapine when antidepressants were prescribed for general medical indications and specific psychiatric indications.
Rates of potential antidepressant overprescribing were highest when they were prescribed for non-specific psychiatric indications (18%), followed by specific psychiatric indications (3.5%) and general medical indications (2.5%). As shown in Supplementary Tables S4   and S5 , the most common non-specific psychiatric indications for SSRIs and mirtazapine were non-specific depressive and anxiety symptoms, depressive symptoms related to loss of a spouse, unspec- vs outpatient), nursing home residence (OR 5.75, 95% CI 2.88-11.50 vs community dwelling), increasing number of medical conditions (P = 0.006 for trend), and increasing number of emergency room visits (P = 0.0001 for trend) and hospitalizations (P < 0.0001 for trend) in the year preceding the index date when antidepressants were prescribed for general medical indications (Table 3) The percent values represent the potential AD overprescribing in the respective characteristic strata. Potential AD overprescribing was determined by the review of the complete medical record information available. P-values are for statistical comparisons of the frequencies of potential AD overprescribing within an indication type. For example, the frequencies of potential AD overprescribing differed significantly across age strata in the general medical indication group (ranging from 4.1% in the 65-69 y age stratum and increasing to 46.4% in the 90+ y age stratum; P-value for comparison <0.0001). By contrast, there were no significant differences in the potential AD overprescribing frequencies across the age strata in the specific psychiatric indication group (P = 0.51) and in the non-specific psychiatric indication group (P = 0.61). The AD prescription was found to represent potential overprescribing by the review of the complete medical record information available.
b
All odds ratios and P-values represent the comparative risk of potential antidepressant overprescribing between strata for a given risk factor, by general antidepressant indication. Statistical testing for linear trends in ORs was conducted, where relevant, by equidistant coding of each stratum (P-trend). For example, when antidepressants were prescribed for specific psychiatric indications, there were nonsignificant associations between having 2 (P = 0.83) or 3 (P = 0.16) outpatient prescribers in the year preceding the incident antidepressant prescription and the risk of potential antidepressant overprescribing as compared with the reference group (having 0-1 outpatient prescribers). Having four or more outpatient prescribers significantly increased the risk of potential antidepressant overprescribing, compared with the reference group (P = 0.01). Formal testing of linear trend in odds ratios was statistically significant (P-trend = 0.003). All analyses were adjusted for sex, age (six strata), calendar year (four strata), non-white race (Blacks, Asians, mixed race, Hispanic, and Other types as self-reported by persons), and education level (>HS vs ≤HS).
c P-value testing for a linear trend in the ORs by equidistant coding of each stratum (e.g., 0, 1, 2, etc.).
d
Other settings include nursing home, emergency room, and unknown settings.
e Includes telephone, email, online medical portal, and other types of non-office visits.
f OR was non-estimable because of small sample size and corresponding complete separation of persons into AD prescriptions that were either all "justified" or all "unjustified".
g Other chronic conditions being treated at time of incident AD prescription.
h Other prescription medications taken at time of incident AD prescription.
i Number of unique health care providers who prescribed at least one medication in the 365 d before incident AD prescription.
T scores abstracted from electronic health records. 36 A large study that used National Ambulatory Medical Care Survey (NAMCS) data to report medication prescribing trends to a nationally representative sample of elderly adults (totaling 96 996 office based physician visits) showed high rates of anticholinergic medication prescribing. 12 The list of high-risk anticholinergic medications included tricyclic antidepressants and the SSRI, paroxetine. In our study, tricyclic antidepressants accounted for 16% of antidepressant prescriptions, but relatively few cases of antidepressant overprescribing. Instead, potential overprescribing of antidepressants in our study mainly occurred with newer antidepressants, such as SSRIs, SNRIs, and mirtazapine, which were often prescribed for nonspecific psychiatric symptoms and subthreshold psychiatric diagnoses (e.g., adjustment disorders, bereavement, etc.). Our findings are thus consistent with previous studies documenting the use of antidepressants for mild or poorly defined mental health conditions or unspecified psychiatric or somatic symptoms. 4, 20, 37, 38 Bereavement and adjustment disorder diagnoses can be quite severe and at times difficult to distinguish from major depressive disorder. 39, 40 Without data on the severity and duration of depressive symptoms, it is not possible to determine the number of patients in our study who were prescribed antidepressants after receiving bereavement of adjustment disorder diagnoses, but may have been better characterized as having major depression or subthreshold depression. However, this is less of a concern for the present study, which focuses on prescribing behavior, and accounts specifically for the diagnoses prompting an antidepressant prescription, as they appeared in the medical records. Antidepressants are generally not recommended for the treatment of adjustment disorders, which are expected to resolve with time and are best treated with psychotherapy. 41 Although bereavement is no longer exclusionary for a diagnosis of major depression, antidepressant treatment is generally reserved for cases of bereavement where a moderate or severe depressive syndrome is diagnosed. 42 In our study, we did not classify antidepressant prescribing for subthreshold depression and dysthymic disorder as potential overprescribing. Dysthymic disorder (persistent depressive disorder) is an accepted indication for antidepressants, based on reasonably strong evidence. 43 The antidepressant treatment of subthreshold depression (depressive disorder, not otherwise specified), which is distinct from adjustment disorders, 44 is relatively under-studied. In the elderly, subthreshold depression is more common than major depression, 45 and antidepressants may be helpful for patients with subthreshold depression and severe mood symptoms. 44 However, we were not able to distinguish between patients with severe vs milder subthreshold depression that may not respond well to antidepressant treatment. 46 The reasons for potential antidepressant overprescribing in our study remain unclear, but may include the availability of agents that are safer for use in the elderly, the improved detection of emotional distress in geriatric patients, and the increasing use of antidepressants in general practice. 47 The challenges associated with managing a large number of co-occurring chronic health conditions during brief office visits may also be an important factor 48 -one that we were unable to assess directly in this research. However, potential antidepressant overprescribing in our study was associated with factors representing higher clinical complexity or severity. These factors included nursing To our knowledge, our study is the first to link new antidepressant prescriptions in response to telephone, e-mail, or electronic portal messages with potential antidepressant overprescribing in elderly patients. These platforms are increasingly important for disease man- most antidepressant prescribing occurs. 51 Third, reviewing the records of cases for which antidepressants were prescribed for non-specific symptoms may have reduced the overestimation of potential antidepressant overprescribing, but there were insufficient resources for applying the same level of scrutiny over all cases of appropriate antidepressant prescribing, as we defined it. This limitation may be especially important in view of growing evidence that several psychiatric diagnoses, especially in primary care settings, do not conform to diagnostic criteria. 51 As such, it is unknown to what degree antidepressant prescribing for specific indications, such as depressive disorder, not otherwise specified, may have been better classified as potential over- We conclude that potential antidepressant overprescribing in a large cohort of elderly patients mainly involved the use of newer antidepressants for non-specific psychiatric symptoms and indications.
However, the majority of incident antidepressant starts did not represent potential overprescribing. When overprescribing occurred, it was associated with factors representing higher multimorbidity, clinical complexity, and severity-and with antidepressant prescribing that did not involve face to face interaction of patients with prescribers.
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